Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Impact
The resolution emphasizes concerns arising from the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, which overturned nearly fifty years of established reproductive rights and returned the power to regulate abortion to state legislatures. This shift allows states to impose stricter regulations on abortion, potentially affecting access to vital health care services, including medication abortions. By urging congressional action, the resolution aims to safeguard abortion access in Hawaii amid evolving legal challenges that may threaten medical providers' ability to offer mifepristone.
Summary
Senate Resolution 42 (SR42) urges members of Hawaii's congressional delegation to monitor the case of The Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. The resolution seeks to limit the potential impacts of the case that could restrict access to safe abortion options, particularly the medication mifepristone which has been approved for use in medical terminations of pregnancy. SR42 reflects the state's concerns about maintaining access to reproductive health care following significant legal changes regarding abortion rights at the federal level.
Contention
A notable point of contention surrounding SR42 is the ongoing legal battle regarding the FDA's approval of mifepristone. The resolution expresses concern that a ruling in the aforementioned case could effectively ban the drug nationwide, significantly limiting health care providers' ability to prescribe it, even in states where abortion remains legal. This situation presents a critical challenge for reproductive health rights as further court interventions could complicate the provision of abortion services and undermine ongoing efforts to protect such access on a federal level.
Same As
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Members Of Hawaii's Congressional Delegation To Monitor The Alliance For Hippocratic Medicine V. U.s. Food And Drug Administration And Take Action To Limit The Case From Further Restricting Access To Safe Abortion Options.
Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Governor, Department Of Human Services, And Department Of Health To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Governor, Department Of Human Services, And Department Of Health To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Members Of Hawaii's Congressional Delegation To Introduce Legislation To Expand The National Flood Insurance Program To Include Lava And Earthquake Insurance.
Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.
Urging The Members Of Hawaii's Congressional Delegation And The Biden Administration To Call For An Immediate, Permanent Bilateral Ceasefire In Gaza And The Return Of All Hostages, And To Continue Negotiations For Lasting Peace In The Region.
Urging The Members Of Hawaii's Congressional Delegation To Introduce Legislation To Expand The National Flood Insurance Program To Include Lava Insurance.
A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.